scholarly journals Development of fixed-time artificial insemination protocols for locally adapted Curraleiro Pé-Duro cows

2016 ◽  
Vol 68 (5) ◽  
pp. 1159-1167 ◽  
Author(s):  
R.D. Tortorella ◽  
M.R. Modesto ◽  
J.P. Neves ◽  
A.F. Ramos
Keyword(s):  
Body Condition Score ◽  
Hormonal Treatment ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Device Removal ◽  
Condition Score ◽  
Equine Chorionic Gonadotropin ◽  
Hot Environments ◽  
To Receive ◽  
Intravaginal Device

ABSTRACT Two experiments were conducted aiming to evaluate the effects of two ovulatory inducers (Exp.1) and equine chorionic gonadotropin (eCG; Exp.2) on follicular and luteal dynamics in a fixed-time AI (FTAI) protocol in locally adapted Curraleiro Pé-Duro cows. In Exp. 1 multiparous cows (n=12) received an intravaginal device containing 1g of progesterone (P4) for 8 days and 2mg of estradiol benzoate (EB) intramuscularly (IM) at device insertion (Day 0). At device removal (Day 8) 0.150mg of Sodium D-Cloprostenol was administered IM and the cows were randomly assigned to receive 1mg of EB (EB8) or 1mg of estradiol cypionate (EC8) IM, or to not receive any ovulatory inducer (Control). All the animals participated in all treatments (crossover). The interval from P4 removal to ovulation was shorter and less variable in the EB8 treatment group (P≤0.05). In Exp. 2 (crossover), multiparous cows (n=12) received the same hormonal treatment as the EB8 group in Exp.1. At device removal (Day 8) cows were randomly assigned to receive 300UI of eCG IM or to not receive eCG (Control). No difference was ascertained on follicular and luteal parameters in Exp. 2 (P>0.05). We concluded that EB can be used as the ovulatory inducer (Exp. 1) in a FTAI protocol in Curraleiro Pé-Duro cows. However, eCG (Exp. 2) was not able to stimulate follicular and luteal development. This result is probably due to the adaptive capacity of Curraleiro Pé-Duro cows that maintained a satisfactory body condition score even in dry and hot environments.

8 EFFECT OF SEMEN TYPES (SEXED v. NONSEXED) ON CONCEPTION RATES OF GIROLANDO HEIFERS INSEMINATED IN FIXED-TIME AI

2010 ◽  
Vol 22 (1) ◽  
pp. 162
Author(s):  
J. Almeida ◽  
O. A. Resende ◽  
D. L. Silveira
Keyword(s):  
Body Condition Score ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Sao Paulo ◽  
São Paulo ◽  
Device Removal ◽  
Conception Rates ◽  
Sexed Semen ◽  
Condition Score ◽  
Intravaginal Device

With the goal of optimizing protocols, fixed-time artificial insemination (FTAI) was performed under field conditions in a study to evaluate conception rates in Girolando (5/8) heifers (18 to 24 months of age) treated with estradiol benzoate (BE) to induce ovulation. Forty heifers were allocated to 2 groups with 20 animals each: GI-sexed semen (2 million spermatozoa/dose) and GII-nonsexed semen (20 million spermatozoa/dose), with body condition score (BCS) of 3.0 ± 0.14 (scale of 1 to 5), middleweight of 335 ± 38 kg, so that it was made for reutilization of progesterone device. On Day 0 (morning), the animals received 2.0 mg of BE (RIC-BE®,Tecnopec, São Paulo, Brazil), 0.075 mg of D-cloprostenol (Prolise®, ARSA S.R.L., Buenos Aires, Argentina), and an intravaginal device of 1 g of progesterone (Primer®, Tecnopec). On Day 8 (morning) the device was removed and 0.075 mg of D-cloprostenol was managed in the GI animals, then these animals received 1.0 mg of BE 24 h after device removal. The insemination was in the late afternoon of Day 10 with a 6-hour delay (4 to 6 pm). The GII animals received Primer previously used for 8 days (being used in the GI animals under the same protocol). After pregnancy diagnosis at 60 days, a third group was created (GIII) using the not-pregnant animals of GI and GII. In GIII, Primer from third use [disinfected in solution Kilol®-L 1:250 (Quinabra, São Paulo, Brazil) and rinsed with water, dried, and packed in plastic sacks and kept for 60 days] was used following the GI protocol with sexed semen. There were no significant differences (P > 0.05) in the conception rates of 40, 58, and 65% among groups GI (8/20), GII (11/20), and GIII (13/20). These results indicate very good conception rates for heifers, contrary to recommendations of commercial companies of sexed semen that alert for the conception rate for mated animals to be lower when using FTAI and mating protocols in mass, compared with that of AI after estrus observation.

39 EFFECT OF TIME OF FIXED-TIME AI ON PREGNANCY RATES IN ZEBU CROSS-BRED BEEF HEIFERS TREATED WITH PROGESTERONE RELEASING DEVICES AND ESTRADIOL CYPIONATE

2010 ◽  
Vol 22 (1) ◽  
pp. 177 ◽  
Author(s):  
M. Ramos ◽  
L. Cutaia ◽  
P. Chesta ◽  
G. A. Bó
Keyword(s):  
Bos Taurus ◽  
Body Condition Score ◽  
Bos Indicus ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Pregnancy Rates ◽  
Beef Heifers ◽  
Treatment Groups ◽  
Condition Score ◽  
To Receive

Two experiments were designed to evaluate the effect of the timing of fixed-time AI (FTAI) in relation to the removal of an intravaginal progesterone-releasing device (1 g of progesterone, DIB, Syntex SA, Buenos Aires, Argentina) on pregnancy rates in Bos indicus × Bos taurus cross-bred heifers. In experiment 1, 285 Bonsmara × zebu cross-bred heifers, between 18 and 24 months of age and with a body condition score (BCS) between 3.0 and 3.5 (1-5 scale) were used. On the day of initiation of treatment (Day 0), the heifers’ ovaries were palpated (92% of them had a CL) and they received a new DIB plus 2 mg of estradiol benzoate (EB; Syntex SA) and 250 μg of cloprostenol (Ciclase DL, Syntex SA). On Day 8, DIB devices were removed and all heifers received 250 μg of Ciclase plus 0.5 mg of estradiol cypionate (ECP; Cipiosyn, Syntex SA). At that time the heifers were randomly divided to receive FTAI between 48 to 49 h, 53 to 54 h, or 58 to 59 h after DIB removal. The heifers underwent FTAI with semen from 4 bulls by 2 inseminators. In experiment 2, 260 heifers from the same group as those used in experiment 1 (87% with a CL) were treated exactly as those in experiment 1, except that previously used DIB was inserted on Day 0. Pregnancy diagnosis was performed 30 days post-fixed-time AI by ultrasonography. The data were analyzed by logistic regression, taking into account the effect of time of FTAI, semen, and inseminator on pregnancy rates. In experiment 1, pregnancy rates were lower (P = 0.04) in the heifers undergoing FTAI between 48 and 49 h after DIB removal (46/95, 48.4%) than those undergoing FTAI 53 to 54 h (61/99, 61.6%) or 58 to 60 h (57/91, 62.6%) after DIB removal. However, no differences in pregnancy rates were found (P = 0.72) in experiment 2 between the 3 treatment groups, with 39/91 (42.9%) for the 48 to 49 h group, 45/89 (50.6%) for the 53 to 54 h group, and 35/89 (43.8%) for the 58 to 59 h group. There was no effect of the semen or inseminator (P > 0.2) in either experiment. We conclude that when Bos indicus × Bos taurus beef heifers are synchronized with new DIB devices and ECP, higher pregnancy rates are obtained in heifers undergoing FTAI late (between 53 to 60 h after DIB removal) than in those undergoing FTAI early (48 to 49 h after DIB removal). However, time of insemination does not apparently affect pregnancy rates when Bos indicus × Bos taurus beef heifers are synchronized with previously used DIB devices and ECP.

178 USE OF A NEW INTRAVAGINAL DEVICE TO RELEASE PROGESTERONE IN FIXED-TIME EMBRYO TRANSFER EMBRYO RECIPIENTS

2010 ◽  
Vol 22 (1) ◽  
pp. 247
Author(s):  
J. R. V. Pimentel ◽  
P. H. P. Miguez ◽  
A. Kehrle ◽  
E. H. Madureira ◽  
F. A. Braga ◽  
...  
Keyword(s):  
Embryo Transfer ◽  
Body Condition Score ◽  
Block Design ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Sao Paulo ◽  
P Value ◽  
São Paulo ◽  
Condition Score ◽  
Intravaginal Device

Progestagen-releasing devices are commonly used for fixed-time artificial insemination and fixed-time embryo transfer (FTET). The aim of this study was to evaluate the efficacy of a new progesterone-releasing intravaginal device made of poly(3-hydroxy)butyrate-valerate copolymer (PHB-V) and poly-ϵ-caprolactone (PCL; Progestar®, Innovare, São Paulo, Brazil) to synchronize crossbredcows and heifers for FTET by determining ovulation, conception, and pregnancy rates. A total of 205 recipients ranging in age from 2 to 8 years (heifers, n = 77; non-suckled cows, n = 69; suckled cows, n = 59) were used on 3 different farms during February, March, and April 2008. The experimental design was a generalized block design (cyclicity, body condition score, postpartum interval, and animal category, i.e. heifers, suckled, or non-suckled cows), with 2 different synchronization treatments for FTET (Progestar® v. Crestar®). Cows were assigned to either Crestar® (norgestomet ear implants; Intervet Schering-Plough, Kenilworth, NJ, USA; n = 103) or Progestar® (PHB-V; n = 102) treatments. All groups were treated with 2 mg of estradiol benzoate i.m. (Innovare) and received the intravaginal or auricular device according to their group (Day 0). Together with P4 device withdrawal (Day 8), all animals received 400 IU of eCG i.m. (Novormon®, Schering-Plough) and 500 μg i.m. of PGF2α, (Sincrocio®, Ouro Fino, Brasil). On Day 9, all cows were treated with 1 mg of estradiol benzoate (Innovare) and the innovulation was performed on Day 17. Embryos were maintained at 37°C during the innovulation period. The percentage of usable recipients (AR) based on the presence of a functional CL on the day of embryo transfer, conception rate (numbers of pregnant recipients of the total number transferred; CR), and pregnancy rate (numbers of pregnant recipients of the total number synchronized; PR) were determined by ultrasonography 23 days after embryo transfer. Data were submitted to ANOVA (PROC GLM, SAS Institute Inc., Cary, NC, USA) and significant differences were considered to have a P-value of <0.05. None of the interactions were significant and there was no effect of treatment on AR (72.8% v. 83.3%), CR (47.9% v. 42.7%), and PR (34.7% v. 35.0%) for Progestar® v. Crestar® groups, respectively. This experiment showed that Progestar® was as efficacious as Crestar® to synchronize crossbred cows and heifers for FTET. FAPESP-Fundação de Amparo à Pesquisa do Estado de São Paulo and CNPq-Conselho Nacional de Desenvolvimento Científico e Tecnológico.

7 INFLUENCE OF ESTRUS EXPRESSION AND TREATMENT WITH GnRH ON PREGNANCY RATES IN BEEF CATTLE SYNCHRONIZED WITH PROGESTERONE DEVICES AND ESTRADIOL AND INSEMINATED AT A FIXED-TIME

2017 ◽  
Vol 29 (1) ◽  
pp. 111 ◽  
Author(s):  
G. A. Bó ◽  
A. Cedeño ◽  
A. Tribulo ◽  
S. Andrada ◽  
R. Tribulo ◽  
...  
Keyword(s):  
Logistic Regression ◽  
Beef Cattle ◽  
Body Condition Score ◽  
Fixed Time ◽  
Beef Cows ◽  
Pregnancy Rates ◽  
Device Removal ◽  
Oestradiol Benzoate ◽  
Condition Score ◽  
To Receive

We have previously shown that expression of oestrus significantly influences the time of ovulation and pregnancy rates to timed-AI (P/TAI) in beef cattle synchronized with progesterone devices and oestradiol (Bó et al. 2016 Theriogenology 86, 388–396). Furthermore, delaying TAI from 48 h to 54–58 h after device removal improved P/TAI of those animals not showing oestrus by 48 h. The objective of the present study was to determine whether the administration of GnRH to those animals not showing oestrus by 48 h after device removal had an impact on P/TAI. Non-lactating and suckled beef cows and heifers (Bonsmara, Brangus, and Braford; n = 868), with a corpus luteum (CL) or a follicle ≥8 mm in diameter detected by ultrasonography (Mindray DP 30 Vet, 7.5 MHz, China) and body condition score 2 to 4 (1 to 5 scale) were synchronized in 3 replicates. On Day 0, animals received a progesterone device (DIB 0.5 g, Zoetis, Argentina) and 2 mg of oestradiol benzoate (Von Franken, Argentina). On Day 8, DIB were removed and cows received 0.150 mg of D+cloprostenol (Río de Janeiro, Argentina) plus 0.5 mg oestradiol cypionate (Cipiosyn, Zoetis). In addition, all cows were tail-painted on the sacrococcygeal area (CeloTest, Biotay, Argentina) at DIB removal and were observed to determine the expression of oestrus, according to the percentage of paint loss (PL) 48 h later. The animals that showed oestrus (PL > 30%) were recorded and TAI at that time while those with PL ≤ 30% (not in oestrus) were randomly allocated to receive 100 μg of gonadorelin (GnRH; Gonasyn, Zoetis) or no treatment and TAI between 54 to 58 h after DIB removal. Pregnancy was diagnosed by ultrasonography at 45 days after TAI, and data were analysed by logistic regression. There were no significant differences among replicates, inseminators, semen source or animal class (dry cows, suckled cows or heifers; P > 0.11). However, animals showing oestrus by 48 h after DIB removal had higher P/TAI (371/666; 55.7; P < 0.04) than those that did not show oestrus (96/202; 47.5%). Within animals not showing oestrus at 48 h, those that were in oestrus by the TAI at 54 to 58 h had higher P/TAI (71/124, 57.3%; P < 0.01) than those that did not show oestrus within that period (27/78; 34.6%). In addition, P/TAI was higher (P < 0.01) in animals that received GnRH (66/113; 58.4%) than in those that did not receive GnRH (30/89; 33.7%). In conclusion, the expression of oestrus significantly affected P/TAI in beef cattle synchronized with progesterone devices and oestradiol. Furthermore, treatment of animals not showing oestrus by 48 h after DIB removal with GnRH resulted in improved P/TAI performed 6 to 10 h later.

30 OVULATION AND PREGNANCY RATES IN CYCLING NELLORE HEIFERS AFTER FIXED-TIME ARTIFICIAL INSEMINATION PROTOCOLS USING DIFFERENT CONCENTRATIONS OF PROGESTERONE, ASSOCIATED OR NOT WITH eCG

2010 ◽  
Vol 22 (1) ◽  
pp. 173
Author(s):  
M. F. Pegorer ◽  
R. L. Ereno ◽  
R. A. Satrapa ◽  
C. M. Barros
Keyword(s):  
Hormonal Treatment ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Pregnancy Rates ◽  
Repeated Measurements ◽  
Blood Levels ◽  
Dominant Follicle ◽  
Device Removal ◽  
Follicle Diameter ◽  
Intravaginal Device

The objective of the present study was to evaluate the influence of different P4 concentrations, associated or not with eCG, in the ovulation and pregnancy rates of Nellore heifers submitted to hormonal protocols for FTAI. In experiment (exp.) 1, heifers (n = 15) presynchronized with a hormonal treatment were randomly allocated in 4 groups. At the time of intravaginal device insertion (Day 0) all animals received 2 mg of estradiol benzoate (EB) and a intravaginal progesterone-releasing device containing 0.558 g of P4 (Triu®, Biogenesis Bago, Buenos Aires, Argentina; group 0.5G, n = 4) or 1g of P4 (Cronipres®, Biogenesis Bago; group 1G, n = 4), or 0.558 g of P4 and PGF2α (150 μg of D-cloprostenol, group 0.5G/PGF, n = 4), or 1 g of P4 and PGF2α (group 1G/PGF, n = 3). Eight days later (Day 8), PGF2α (150 μg D-cloprostenol) was administered to all heifers, and the P4 source was removed. Twenty-four hours after removing the intravaginal device (Day 9), the heifers were treated with EB (1 mg, i.m.). Blood samples were collected on Days 0, 1, 2, 4, 8, and 10 to evaluate plasma P4 concentration. In exp. 2, cycling Nellore heifers (n = 292) were treated with the same protocols as in the exp. 1. However, 30 to 36 h later all animals were FTAI on Day 10. In exp. 3, heifers (n = 459) received the treatments described for groups 0.5G/PGF and 1G/PGF associated with 300 IU of eCG (i.m. groups 0.5G/PGF/eCG and 1G/PGF/eCG) at the time of intravaginal device removal (Day 8). In a subset of heifers from each group, ovarian ultrasonography was performed to determine the diameter of the dominant follicle on Day 9 (exp.3) and the ovulation rate on Day 12 (exp. 2 and 3). ANOVA for repeated measurements was used to compare P4 levels, and the binary variables (ovulation and pregnancy rates) were analyzed by logistic regression. In exp. 1, P4 concentrations were higher in animals that received 1.0 compared with 0.558 g of P4, and lower in heifers that received PGF2α on Day 0. In both exp. 2 and 3 there were no significant differences in ovulation (65 to 77%) and pregnancy (exp.2: 26 to 33%; exp.3: 39 to 43%) rates among the several groups. In exp. 3, the animals that received 0.558 g of P4 had a larger diameter of the dominant follicle on Day 9 compared with heifers treated with 1.0 g (10.3 ± 0.2 v. 9.3 ± 0.2 mm; P < 0.01). It is concluded that reduction of P4 concentration in the intravaginal device or the administration of PGF2α at the beginning of the treatments decreases blood levels of P4 between Days 1 and 8 of the FTAI protocols. However, although the use of intravaginal devices with lower P4 contributed to increase the dominant follicle diameter on Day 9, there was no significant increase on ovulation and pregnancy rates. Additionally, the association of eCG with FTAI protocols did not improve follicular growth or ovulation and pregnancy rates. Supported by FAPESP (Sao Paulo, Brazil).

163 Treatment with gonadotrophin-releasing hormone at the time of AI in beef heifers that fail to express oestrus after an estradiol-based synchronisation protocol improves pregnancies per AI

2020 ◽  
Vol 32 (2) ◽  
pp. 208
Author(s):  
A. Butler ◽  
H. Butler ◽  
G. Cesaroni ◽  
R. Alberio ◽  
S. Perez Wallace ◽  
...  
Keyword(s):  
Pregnancy Loss ◽  
Fixed Time ◽  
P Value ◽  
Device Removal ◽  
Releasing Hormone ◽  
Condition Score ◽  
Gonadotrophin Releasing Hormone ◽  
To Receive ◽  
Angus Heifers ◽  
Intravaginal Device

Oestrus expression between progesterone (P4) withdrawal and fixed-time AI (FTAI) has been shown to improve pregnancies per AI (P/AI) by 27% in beef cattle. As a result, cattle that do not express oestrus after P4 withdrawal present a challenge to the efficiency of FTAI. The present study was designed to test the hypothesis that administration of gonadotrophin-releasing hormone (GnRH) at the time of AI in heifers that do not express oestrus can improve fertility. Two-year-old Angus heifers (n=1032) with a condition score of 2.75 to 3.5 at two locations in Argentina were used. On Day 0, heifers received an intravaginal device containing 0.5g of P4 (Cronipres, Biogenesis) and 2mg of oestradiol benzoate intramuscularly (Bioestrogen, Biogenesis). On Day 8, devices were removed and heifers received 150µg of d-cloprostenol intramuscularly (Enzaprost, Biogenesis), 0.5mg of oestradiol cipionate intramuscularly (Croni-Cip, Biogenesis), and an oestrus detection patch (Estrotect, Rockway Inc.). On Day 10, AI was performed in all heifers 50 to 54h after device removal. Heifers were categorised based on oestrus expression, and those that did not express oestrus were randomised to receive 100µg of gonadorelin acetate intramuscularly (Gonasyn, Syntex; n=158) concurrent with AI or remain as untreated controls (n=151). Pregnancy was determined using ultrasonography at Days 38 and 111 after AI. Differences in fertility were evaluated using generalised linear mixed models, and the results are shown in Table 1. Oestrus expression between device removal and FTAI was 70.1% (723/1032). Pregnancies per AI at Days 38 and 111 were different between groups (P&lt;0.01). Heifers that expressed oestrus had greater P/AI than those that did not regardless of treatment (P&lt;0.01). However, in heifers that did not express oestrus, treatment with GnRH at the time of AI resulted in greater P/AI than in control heifers (P=0.004). Similarly, P/AI at Day 111 were greater in heifers that expressed oestrus than in those that did not regardless of treatment (P&lt;0.01). Heifers that did not express oestrus and were treated with GnRH had greater P/AI than those that did not express oestrus and remained as controls (P=0.02). Pregnancy loss between Days 38 and 111 was not different between groups; however, there was a tendency (P=0.06) for greater pregnancy loss in heifers that did not express oestrus and were treated with GnRH compared with heifers that expressed oestrus. In summary, treatment with GnRH at the time of AI is a suitable strategy to improve P/AI in heifers that fail to exhibit oestrus after an oestradiol-based synchronisation protocol. However, this strategy appears to increase pregnancy loss, and thus further research is needed to confirm this observation and the mechanisms underlying it. Table 1.Pregnancies per AI (P/AI) and pregnancy loss (%; no. in parentheses) in Angus heifers based on oestrus expression and treatment with GnRH Group P/AI Day 38 P/AI Day 111 Pregnancy loss Oestrus 68.9 (498/723)A 65.2 (471/723)A 5.4 (27/498) No oestrus control 29.8 (45/151)B 28.5 (43/151)B 4.4 (2/45) No oestrus + GnRH 45.6 (72/158)C 40.5 (64/158)C 11.1 (8/72) P-value &lt;0.001 &lt;0.001 0.15 A-CValues within a column with different superscripts differ significantly (P&lt;0.05).

8 EFFECT OF DURATION OF TREATMENT WITH PROGESTERONE VAGINAL DEVICES ON PREGNANCY RATES IN CROSS-BRED ZEBU CATTLE ARTIFICIALLY INSEMINATED AT A FIXED TIME

2006 ◽  
Vol 18 (2) ◽  
pp. 112
Author(s):  
E. Balla ◽  
D. Pincinato ◽  
D. Maraña ◽  
L. C. Peres ◽  
L. F. K. Borges ◽  
...  
Keyword(s):  
Body Condition Score ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Pregnancy Rates ◽  
Zebu Cattle ◽  
Duration Of Treatment ◽  
Treatment Groups ◽  
Condition Score ◽  
To Receive ◽  
Zebu Cows

Three experiments were designed to evaluate the effect of the duration of treatment with progesterone (P4) vaginal devices (1 g of P4, Triu-B; Biog�nesis, Buenos Aires, Argentina) on pregnancy rates in crossbred zebu cattle artificially inseminated at a fixed time (FTAI). In Exp. 1, 371 non-lactating multiparous crossbred zebu cows with a body condition score (BCS) between 2.0 and 3.0 out of 5 were randomly allocated to one of nine treatment groups in a 3 � 3 factorial design. On Day 0, all cows received 2 mg of estradiol benzoate (EB, Bioestrogen; Biog�nesis) i.m. and were divided into groups to receive a new Triu-B device, a once-previously-used Triu-B (2nd-use), or a Triu-B that was previously used twice (3rd-use) and in which three silicone rings (2 cm in length) impregnated with 100 mg P4 each were threaded through the wings of the device. Triu-B devices are currently approved for re-use up to three times. Cows were further subdivided to have their Triu-B devices removed on Days 7, 8, or 9. PGF (150 �g D(+)cloprostenol, Enzaprost-DC; Biog�nesis) was administered i.m. at the time of Triu-B removal, followed by 1 mg EB 24 h later; all cows were FTAI 52 to 56 h after Triu-B removal. In Exp. 2, 417 crossbred zebu heifers, 20 to 26 months of age and BCS between 2.5 and 3.5, were treated similarly to the cows in Exp. 1, except that only new or 3rd-use Triu-B were used. In Exp. 3, 836 crossbred zebu heifers, similar to those used in Exp. 2, were also treated similarly to the cows in Exp. 1, but in this case, Triu-B devices were inserted for 8, 9, or 10 days. Pregnancy rates were determined by ultrasonography 50 to 60 days after FTAI and were analyzed by logistic regression. In Exp. 1, there were no significant effects of duration of treatment [7 days: 69/137 (50.4%), 8 days: 68/139 (48.9%), or 9 days: 41/95 (43.2%); P = 0.28], or type of Triu-B used (P = 0.91; new Triu-B: 47.7%, 2nd-use: 48.9%, or 3rd-use: 47.2%). In Exp. 2, there were no significant effects of duration of treatment [7 days: 76/139 (54.7%), 8 days: 63/143 (44.1%), or 9 days: 73/135 (54.1%); P = 0.98] or type of Triu-B used (new Triu-B: 48.6% and 3rd-use Triu-B: 53.2%; P = 0.33). In Exp. 3, there was an interaction between duration of treatment and pregnancy rates (P < 0.05). Lower pregnancy rates were obtained in 9- and 10-day treatments than in 8-day treatments, but only when previously used Triu-B devices were used. Pregnancy rates were: new Triu-B for 8 days: 42/89 (47.2%), 9 days: 37/90 (41.1%), and 10 days: 41/91 (45.1%); 2nd-use Triu-B for 8 days: 51/103 (49.5%), 9 days: 39/104 (37.5%), and 10 days: 39/109 (35.8%); 3rd-use Triu-B for 8 days: 52/90 (57.4%), 9 days: 31/90 (34.4%), and 10 days: 25/70 (35.7%); P < 0.01. Results demonstrate that treatment of crossbred zebu cattle with P4 devices for 7 to 10 days results in comparable pregnancy rates when new Triu-B devices are used. However, pregnancy rates decreased when previously used Triu-B devices were inserted for more than 8 days.

Effect of recombinant bovine somatotropin on pregnancy rates of Nellore cows resynchronized with the use of new DIB and third use, and inseminated at fixed-time

2015 ◽  
Vol 4 (1) ◽  
pp. 356-362
Author(s):  
Josemara Silva Santos ◽  
Tania Cavalcante ◽  
Francisca Elda Ferreira Dias ◽  
Domenica Palomaris Mariano de Souza ◽  
Alencariano J.S. Falcão ◽  
...  
Keyword(s):  
Artificial Insemination ◽  
Linear Models ◽  
Plasma Concentrations ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Pregnancy Rates ◽  
Recombinant Bovine Somatotropin ◽  
Equine Chorionic Gonadotropin ◽  
Rectal Palpation ◽  
Intravaginal Device

The objective of the experiment was to evaluate the effects of recombinant bovine somatropin (rbST), and the reuse of the progesterone (P4) releasing devices in resynchronization, on the pregnancy rates of Nellore cows submitted to fixed-time artificial insemination. A group of 123 multiparae Nellore cows, was submitted to a resynchronization protocol: on day 0 a Bovine Intravaginal Device (DIB® ) with 1,0g of P4 was implanted, associated with intramuscular administration of 2,0mg of estradiol benzoate (IM); on day 8 DIB was removed; and 1,0mg of estradiol cypionate, 0,15mg of prostaglandin F2? and 300 UI of equine chorionic gonadotropin were administered; on day 10, fixed-time artificial insemination was conducted (FTAI). The cows were randomized into G1 (n=12) – without rbST / with used Bovine Intravaginal Device, G2 (n=50) – without rbST / with new DIB, G3 (n=11) - with rbST / with used DIB and G4 (n=50) – with rbST/ with new DIB. rbST was introduced on the eighth day of the protocol. Sixty days after TAI, pregnancy diagnoses were conducted, via rectal palpation. Blood samples were taken on day 0, 8 and 10 of the protocol, in order to assess P4 plasma concentrations. Pregnancy rates were statistically evaluated through Generalized Linear Models Theory and their significance was tested with Analysis of Deviance. Pregnancy rates were 58%, 40%, 81% and 48% for G1, G2, G3 and G4, respectively, with significant statistical difference for G3. Plasma concentrations of P4 were not statistically different among groups, or collections. In view of the results obtained, we concluded that the administration of rbST in association with P4 DIB, used for the third time, improves pregnancy rates. Estrus resynchronization and re-insemination positively impacted pregnancy rates.

116 PREGNANCY RATES AFTER ADMINISTRATION OF EQUINE CHORIONIC GONADOTROPIN (eCG) AT PROGESTERONE INTRAVAGINAL DEVICE REMOVAL AND 14 DAYS AFTER FIXED-TIME AI IN BEEF CATTLE

2011 ◽  
Vol 23 (1) ◽  
pp. 163 ◽  
Author(s):  
R. Núñez ◽  
T. de Castro ◽  
L. Cutaia ◽  
G. Bó ◽  
A. Menchaca
Keyword(s):  
Beef Cattle ◽  
Pregnancy Rate ◽  
Body Condition Score ◽  
Fetal Loss ◽  
Fixed Time ◽  
Pregnancy Rates ◽  
Control Group ◽  
Device Removal ◽  
Embryo Survival ◽  
Intravaginal Device

An important proportion of embryonic deaths in cattle occur during the critical period of embryo development and maternal recognition of pregnancy. High serum progesterone concentrations during this period are associated to higher embryo survival, and the use of eCG could enhance luteal activity. Two experiments were carried out to evaluate the effect of administering eCG at the time of removal of a progesterone-releasing device and 14 days after fixed-time artificial insemination (FTAI) in beef cattle. Multiparous suckled cows between 60 and 90 days postpartum (n = 297; Exp. 1), and two-year old prepuberal heifers (n = 689; Exp. 2) with a body condition score (BCS) between 3.5 and 5 (1 to 8 scale) were used. At the beginning of the experiments, none of females used had a corpus luteum detected by ultrasonography. Females received an intravaginal device containing 0.5 g progesterone (DIB 0.5, Syntex, Buenos Aires, Argentina) and 2 mg oestradiol benzoate i.m. (Benzoato de Oestradiol, Syntex). Eight days later, 500 μg of cloprostenol (Ciclase DL, Syntex) and 0.5 mg oestradiol cypionate (Cipiosyn, Syntex) were given i.m. and devices were removed; FTAI was performed 52 to 56 h after DIB removal. At the time of device removal, the animals were randomly allocated to 4 groups, to receive 400 IU of eCG i.m. (Novormon, Syntex) or placebo at device removal and/or 14 days after FTAI, in a 2 × 2 factorial design. Control group did not receive eCG. In Exp. 1, nose plates were placed on calves on the day of DIB insertion and left for 10 days in order to prevent suckling. Pregnancy diagnosis was performed by ultrasonography at 30 and 60 days after FTAI. Data were analysed by logistic regression. Pregnancy rate at 30 days after FTAI was affected by treatment (P < 0.05; Table 1). Late embryonic/fetal loss rates (non-pregnant females at 60 days after FTAI over those pregnant at 30 days) were 1.6% (3/182) for cows in Exp. 1 and 4.8% (14/292) for heifers in Exp. 2; no differences were detected among groups. In conclusion, administration of 400 IU of eCG at device removal increases pregnancy rate, both in anestrus cows and heifers. However, the administration of a second dose of eCG 14 days after FTAI suggests a possible effect on embryo survival within the first 30 days of pregnancy in cows but not in heifers. Further studies are required to confirm these results. Table 1.Pregnancy rates after administration of eCG at time of progesterone device removal and/or 14 days after insemination in beef cattle Supported by Syntex.

8 Evaluation of puberty induction protocol in peripubertal beef heifers prior to fixed-time AI programs

2019 ◽  
Vol 31 (1) ◽  
pp. 129
Author(s):  
J. B. S. Borges ◽  
D. S. V. Luiz ◽  
P. R. L. Aguiar ◽  
C. G. B. Berlitz ◽  
G. S. Velho ◽  
...  
Keyword(s):  
Breeding Season ◽  
Body Condition ◽  
Body Condition Score ◽  
Animal Health ◽  
Hormonal Treatment ◽  
Fixed Time ◽  
P Value ◽  
Ovarian Activity ◽  
Beef Heifers ◽  
Condition Score

Beef heifers that conceive early during their first breeding season calve earlier, wean heavier calves, and tend to continue doing so throughout the rest of their reproductive lives. Otherwise, under extensively managed systems in Southern Brazil, only a variable proportion of 2-year-old beef heifers reach puberty before the start of the breeding season. The aim of this study was to evaluate a protocol to induce puberty in peripubertal beef heifers using injectable progesterone (P4) and oestradiol cypionate (EC) to improve pregnancy per AI (P/AI) in fixed-time AI (FTAI) programs. A total of 311 Angus heifers, 24±3 months of age, 3.1±0.3 body condition score (1=emaciated; 5=obese), and 328±41kg of body weight (BW), were examined before FTAI protocol (Day −24) by transrectal ultrasonography to determine reproductive tract score (RTS; 1=prepubertal; 5=pubertal). Prepubertal heifers (RTS 1; 12.8%, 40/311) were excluded from the study. Heifers with RTS=2 (n=271) were assigned to 2 groups: P4 (RTS 2 or 3, n=100) and cyclic (RTS 4 and 5, n=171). Peripubertal heifers were treated on Day −24 with 150mg of injectable P4 IM (Sincrogest® injectable, Ourofino Animal Health, Cravinhos, Brazil) and on Day −12 received 1mg of EC IM (Sincro CP®, Ourofino Animal Health). Cyclic heifers received no hormonal treatment before FTAI protocol. On Day 0, heifers in the P4 group were evaluated again to determine RTS, body condition score, and BW. Induction of puberty was defined by the presence of a follicle &gt;8.5mm (RTS=4) or a corpus luteum (RTS=5). All heifers received an FTAI protocol consisting of 2mg of oestradiol benzoate IM (Sincrodiol®, Ourofino Animal Health) and an intravaginal progesterone implant (1 g; Sincrogest®, Ourofino Animal Health). On Day 8, heifers had implants removed and were injected with 1mg of EC and 500µg of sodium cloprostenol IM (Sincrocio®, Ourofino Animal Health). After 48h, all heifers received an FTAI. Thirty days after AI, the diagnosis of gestation was performed by ultrasonography. Statistics included chi-square and linear regression with coefficients analysed as independent variables, considering a significant P-value of 0.05. On Day 0, percentages of RTS 5, 4, and 3 in the P4 heifers were 37, 27, and 36%, respectively, resulting in 64% of puberty induction. The P/AI was similar (P=0.14) in P4-treated and cyclic heifers (59v. 50.3%, respectively). The regression analysis presented a linear and positive effect of BW on P/AI (P&lt;0.001) in cyclic heifers and a positive influence of BW on RTS (P=0.05) and RTS on P/AI (P=0.008) in P4-treated heifers. The application of RTS system associated with P4 treatment of peripubertal heifers before FTAI protocol improved ovarian activity and might have contributed to higher P/AI, comparable with that achieved in cyclic heifers.

Sign in / Sign up

Export Citation Format

Share Document